Related Experiment Videos
Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes
Annual Review of Immunology
|January 1, 1986
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.
Annals of oncology : official journal of the European Society for Medical Oncology·2016
RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer.
Cell death & disease·2014
The Neuroimmune Circuitry of Peripheral Sensory Neuron Subtypes in Chronic Pain.
Annual review of immunology·2026
The Spectrum of Fibroblast Immune Biology.
Annual review of immunology·2026
The Molecular Logic of Immunoglobulin Heavy Chain Class Switch Recombination.
Annual review of immunology·2026
Decoding Human T Cell Immunity with Artificial Intelligence and Single-Cell Genomics.
Annual review of immunology·2026
Immune Niches in Cancer.
Annual review of immunology·2026
T Cell Receptor Signaling and Immune Tolerance: From Autoimmunity to Cancer Immunity.
Annual review of immunology·2026